Navigation Links
Micromet Presents Update at ASCO 2009 on a Phase 1b Combination Study of Adecatumumab and Docetaxel
Date:6/1/2009

fety, efficacy or tolerability of our product candidates may be discovered upon further analysis of preclinical or clinical trial data, the risk that we or our collaborators will not obtain approval to market our product candidates, the risks associated with reliance on outside financing to meet capital requirements, and the risks associated with reliance on collaborators, including MedImmune, Merck Serono, TRACON and Nycomed, for the funding or conduct of further development and commercialization activities relating to our product candidates. These factors and others are more fully discussed in Micromet's Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2009, filed with the SEC on May 11, 2009, as well as other filings by the company with the SEC.


'/>"/>
SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Micromet to Present New Clinical Data on Blinatumomab at EHA and on Adecatumumab at ASCO
2. Micromet, Inc. to Host Conference Call and Webcast to Report First Quarter 2009 Financial Results on May 6, 2009
3. Micromet Presents Data at AACR Meeting Showing Elimination of Colorectal Cancer Stem Cells by BiTE Antibody MT110
4. Micromet to Present at the Future Leaders in the Biotech Industry Conference on April 2, 2009
5. Micromet Adds Sir Walter Bodmer and Bernard Fox to Its Advisory Panel for BiTE Antibody Therapeutics
6. Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research
7. Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008
8. Micromet to Present at the Cowen Health Care Conference on March 17, 2009
9. Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
10. Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009
11. Micromet Enters Into Agreement for Solid Tumor BiTE Antibody with Bayer Schering Pharma AG

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...FirstCall/--PDLBioPharma,Inc.(PDL)(Nasdaq: PDLI )t...09astheex-dividenddateforits$200millionspecialdivi...ansactioncompletedonNovember2,2009.Thedividendwill...therecorddate,December1,2009.NASDAQhassettheapprox...ommonstockforpurposesoftheex-dividenddateonNovembe...
(Date:11/23/2009)...Call/-YMBioSciencesInc.(NYSEAmex: YMI ;TSX:YM),ali...ndadvancesadiverseportfolioofpromisingcancer-relat...edthatCytopia(ASX:CYT)hascommencedenrollmentofaPha...teredJAK1/JAK2inhibitor.Thetrialisbeingconductedat...topiaintoYMhasbeenpreviouslyannouncedandispendinga...
(Date:11/23/2009)...all/--NeogenCorporation(Nasdaq: NEOG )announcedtod...oardofDirectorsatthecompany,srecentannualmeetingof...erienceinthefood,agriculture,andtradeindustriesand...conomicsatVirginiaTechUniversity.FromJanuary2006un...egotiatorwiththerankofambassador. ,, "Sinceourf...
(Date:11/23/2009)...cidin disinfectant solution and wipes are reliable...t H1N1 and Influenza A., , ...tec Inc, the leading manufacturer of clean room p...infectants have been deemed by the EPA as effecti...emic 2009 H1N1 influenza A virus (the swine flu). ...
Breaking Biology Technology:PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Richard T. Crowder Joins Neogen's Board of Directors 2Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes 2
...-owned businesses to the $1 million annual revenue...s, perhaps none more important than information te...out of the recent Wisconsin Make Mine a Million ...ged to leverage information technology to a greate...rk. , ,The advice they absorbed from the likes of ...
...ch, a partner with the law firm Michael Best & Fr...Riske, the firm,s director of government affairs ....tment of Energy has announced $200 million in new...s funding opportunity is open to applicants with p...and development to design, construction, and opera...
...a Green Bay anti-spam solution provider, has intro...than 100,000 users and 20 million e-mails per day....appliance, was unveiled at this week,s Interop exh...to combat increasing threats from spam, phishing a...eIQ 3.0, the company,s newest anti-spam engine. , ...
Other Biology Technology:Learning from the big boys: With technology, women urged to go gradual 2Learning from the big boys: With technology, women urged to go gradual 3Wisconsin applicants urged to pursue DOE funding for cellulosic biomass 2
(Date:11/23/2009)...ew study by the Wildlife Conservation Society says...wamp in the Republic of Congopart of the "mother l... yearare becoming increasingly threatened by growi...commends protection of the swamp forests adjacent ...e after recent surveys confirmed that high densiti...
(Date:11/23/2009)...E, Calif. -- More than 160 participants gathered t... Keck FUTURES INITIATIVE conference. This year,s t...ists, engineers, and medical researchers to explor...urrounding the emerging field of synthetic biology...ology at Princeton University and this year,s conf...
(Date:11/23/2009)...ngton, CT Current research suggests that a common... The related report by Nichols et al, "Unique Lip...Class of TLR2 Ligands Capable of Enhancing Autoimm... American Journal of Pathology . , Multiple scle...cks the brain and spinal cord, affects nearly 1 in...
Breaking Biology News(10 mins):A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Factors from common human bacteria may trigger multiple sclerosis 2New Way Found to Diagnose Endometriosis 54982 1New Way Found to Diagnose Endometriosis 54982 2New Way Found to Diagnose Endometriosis 54982 3DIA 3rd Annual Clinical Trial Disclosure Workshop Offers Strategies for Creating Effective Registries and Results Databanks 54978 1DIA 3rd Annual Clinical Trial Disclosure Workshop Offers Strategies for Creating Effective Registries and Results Databanks 54978 2Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 1Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 2Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 3Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 4Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 5Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 6
...ncer Center at Thomas Jefferson University in Phil...n regulating aging also blocks prostate cancer cel...nter director Richard Pestell, M.D., Ph.D., hope t...standing the development of prostate cancer and le... member of a family of enzymes called sirtuins tha...
...role in mediating the outcome of competition betwe...-bearing conquistadors in the New World--or, on a ...eria to spread their viruses to competing bacteria...fferent general ways in which bacteria compete wit...egy seems to be particularly effective under diffe...
...als and the general public alike have been acutely...from a flu pandemic. Although many people might st...he infamous 1918-1920 pandemic--and the possibilit...ost trepidation. , Strangely, researchers still... particular strain of the flu virus in that pandem...
Other Biology News:Jefferson scientists find aging gene also protects against prostate cancer development 2Different strategies underlie the ecology of microbial invasions 2Recurrence of a flu pandemic similar to infamous 1918 flu could kill 62 million 2Recurrence of a flu pandemic similar to infamous 1918 flu could kill 62 million 3
CultureWell multiwell cell culture system CWI 50R-1.0 *plate and insert four 24 mm x 50 mm coverslips per insert fifty 1 mm-deep wells per coverslip* *set of 10* from Molecular Probes (Invitrogen)
...uct contains 5 ml of DETACHaBEAD Mouse CD4, polycl...cells from Dynabeads Mouse CD4 (L3T4). Detach pos... Mouse CD4 using DETACHaBEAD Mouse CD4. The isolat...on including flow cytometry, functional studies an...
CoverWell imaging chamber gasket with adhesive, one chamber, 20 mm diameter, 1.0 mm deep *set of 40* from Molecular Probes (Invitrogen)
Rattler Plating Beads from Zymo Research
Biology Products: